1. Assessment of TP53 functionality in chronic lymphocytic leukaemia by different assays; an ERIC‐wide approach. (30th June 2014) Authors: te Raa, G. Doreen; Malčiková, Jitka; Mraz, Marek; Trbusek, Martin; Le Garff‐Tavernier, Magali; Merle‐Béral, Hélène; Greil, Rudolf; Merkel, Olaf; Pospíšilová, Sarka; Lin, Ke; Pettitt, Andrew R.; Stankovic, Tatjana; van Oers, Marinus H.; Eldering, Eric; Stilgenbauer, Stephan; Zenz, Thorsten; Kater,... Journal: British journal of haematology Issue: Volume 167:Number 4(2014:Nov.) Page Start: 565 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ATM and TP53 mutations show mutual exclusivity but distinct clinical impact in mantle cell lymphoma patients. Issue 6 (12th May 2019) Authors: Mareckova, Andrea; Malcikova, Jitka; Tom, Nikola; Pal, Karol; Radova, Lenka; Salek, David; Janikova, Andrea; Moulis, Mojmir; Smardova, Jana; Kren, Leos; Mayer, Jiri; Trbusek, Martin Journal: Leukemia & lymphoma Issue: Volume 60:Issue 6(2019) Page Start: 1420 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. ATR-CHK1 pathway as a therapeutic target for acute and chronic leukemias. (August 2020) Authors: Boudny, Miroslav; Trbusek, Martin Journal: Cancer treatment reviews Issue: Volume 88(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. ChemInform Abstract: New Carbocyclic Nucleosides: Synthesis of Carbocyclic Pseudoisocytidine and Its Analogues. Issue 49 (9th December 2014) Authors: Maier, Lukas; Hylse, Ondrej; Necas, Marek; Trbusek, Martin; Ytre‐Arne, Mari; Dalhus, Bjoern; Bjoraas, Magnar; Paruch, Kamil Journal: ChemInform Issue: Volume 45:Issue 49(2014) Page Start: no Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Impact of gene mutations and chromosomal aberrations on progression-free survival in chronic lymphocytic leukemia patients treated with front-line chemoimmunotherapy: Clinical practice experience. (June 2019) Authors: Spunarova, Michaela; Tom, Nikola; Pavlova, Sarka; Mraz, Marek; Brychtova, Yvona; Doubek, Michael; Panovska, Anna; Skuhrova Francova, Hana; Brzobohata, Anna; Pospisilova, Sarka; Mayer, Jiri; Trbusek, Martin Journal: Leukemia research Issue: Volume 81(2019) Page Start: 75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. NOD/SCID IL2Rγ-null mouse xenograft model of human p53-mutated chronic lymphocytic leukemia and ATM-mutated mantle cell lymphoma using permanent cell lines. Issue 11 (2nd November 2015) Authors: Verner, Jan; Trbusek, Martin; Chovancova, Jana; Jaskova, Zuzana; Moulis, Mojmir; Folber, Frantisek; Halouzka, Roman; Mayer, Jiri; Pospisilova, Sarka; Doubek, Michael Journal: Leukemia & lymphoma Issue: Volume 56:Issue 11(2015:Nov.) Page Start: 3198 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Ofatumumab added to dexamethasone in patients with relapsed or refractory chronic lymphocytic leukemia: Results from a phase II study. Issue 5 (1st April 2015) Authors: Doubek, Michael; Brychtova, Yvona; Panovska, Anna; Sebejova, Ludmila; Stehlikova, Olga; Chovancova, Jana; Malcikova, Jitka; Smardova, Jana; Plevova, Karla; Volfova, Pavlina; Trbusek, Martin; Mraz, Marek; Bakesova, Denisa; Trizuljak, Jakub; Hadrabova, Marketa; Obrtlikova, Petra; Karban, Josef; Smo... Journal: American journal of hematology Issue: Volume 90:Issue 5(2015:May) Page Start: 417 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Overview of available p53 function tests in relation to TP53 and ATM gene alterations and chemoresistance in chronic lymphocytic leukemia. Issue 8 (August 2013) Authors: te Raa, G. Doreen; Malcikova, Jitka; Pospisilova, Sarka; Trbusek, Martin; Mraz, Mark; Garff-Tavernier, Maria Le; Merle-Béral, Hélène; Lin, Ke; Pettitt, Andrew R.; Merkel, Olaf; Stankovic, Tatjana; van Oers, Marinus H.; Eldering, Eric; Stilgenbauer, Stephan; Zenz, Thorsten; Kater, Arnon P. Journal: Leukemia & lymphoma Issue: Volume 54:Issue 8(2013:Aug.) Page Start: 1849 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. PRIMA-1MET cytotoxic effect correlates with p53 protein reduction in TP53-mutated chronic lymphocytic leukemia cells. (February 2020) Authors: Jaskova, Zuzana; Pavlova, Sarka; Malcikova, Jitka; Brychtova, Yvona; Trbusek, Martin Journal: Leukemia research Issue: Volume 89(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Rituximab induces rapid blood repopulation by CLL cells mediated through their release from immune niches and complement exhaustion. (December 2021) Authors: Borsky, Marek; Hrabcakova, Viera; Novotna, Jitka; Brychtova, Yvona; Doubek, Michael; Panovska, Anna; Muller, Petr; Mayer, Jiri; Trbusek, Martin; Mraz, Marek Journal: Leukemia research Issue: Volume 111(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗